Texas Oncology - San Aantonio

San Antonio, Texas 78240

1 studies enrolling now · 1 studies all time

What they study most

HR+ HER2- Breast Cancer

Studies at this site

• Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer — Recruiting now